Syros Pharmaceuticals said it plans to wind down its operations, according to a Securities and Exchange Commission filing. The Cambridge, Mass., company said it would proceed with a voluntary ...
EST Syros Pharmaceuticals (SYRS) trading halted, news pendingDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...
EST Syros Pharmaceuticals (SYRS) trading resumesDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has been given a consensus rating of “Hold” by the five research ...
Syros gets two engine options – a 1.0-litre, 3-cylinder, turbo-petrol which puts out 120hp of power and 172Nm torque. It ...
Kia has already seen over 20,000 interested buyers who have booked themselves brand-new Syros! Here is a look at the premium ...
Newsable Asianet News on MSN18h
Kia Syros to MG Hector: Check out top 5 cars with ADAS Level 2Discover the top 5 cars equipped with ADAS Level 2 technology, offering enhanced safety and convenience features. From Kia ...
The Kia Syros is the latest addition to the lineup of cars in India and comes at a starting price of Rs 9 lakh (ex-showroom).
Kia Syros introduces a range of innovative technologies, including a segment-first Over-the-Air (OTA) software update system.
The manual gearbox remains the preferred choice, while a considerable number of buyers opted for the automatic transmission ...
Syros Pharmaceuticals, which said in November it would cut most of its workforce, said on Friday it will wind down operations. The company's stock dropped 45% to 8 cents in after-hours trading.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback